Acellular pertussis vaccine

Pertussis, acellular component of monovalent or combined vaccines

Title: Guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines; Adopted 1996, TRS no 878, Annex 2


  • Working Group Meeting to develop WHO Guidelines on regulatory preparedness for vaccine non-producing countries in response to Pandemic Influenza emergency, 9-11 June 2015, Tunis Conference Centre, Tunisia


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971